Pharmafile Logo
Pharmafocus logo
Advanced Search

Cambridge

Showing 15 posts of 38 posts found.

cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …

News

Interactions with the Agencies During Drug Development

April 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, NDA, drug development

 NDA would like to invite you to join  Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …

News
Press release
theo_harold

Crescendo Biologics selects current CFO Theodora Harold as new CEO

April 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Cambridge, Crescendo Biologics, Dr Peter Pack, Theo Harold, cfo

Cambridge, UK-based Crescendo Biologics have said current Chief Financial Officer (CFO) Theodora Harold will take over from Dr Peter Pack …

Appointment
arnaud_breabout

Mundipharma name GSK veteran as new Senior Vice President & CFO

November 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president

The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …

Appointment
bicycle_therapeutics

Cambridge start-up secures £40 million to trial innovative cancer drugs

June 16, 2017
Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer

Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …

News
takeda_tokyo_hq

Jobs to go at Takeda as it shuts down Cambridge facility

August 26, 2016
Manufacturing and Production, Medical Communications Cambridge, Jobs, Takeda, closure

Takeda has announced plans to close its facility in Cambridge in the UK, to refocus its research and development operations …

News
lab sign

Medimmune and Cancer Research UK launch new drug discovery lab

September 11, 2015
Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman

MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …

News
AstraZeneca plaque

Cambridge collaboration to boost precision medicine research

July 29, 2015
Research and Development Brabaham Institute, Cambridge, R&D, collaboration

A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …

News

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015
Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

News
New planned building for genomics firm Illumina in Cambridge image

UK pharma’s ‘Golden Triangle’ faces competition from new challengers

June 29, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioGateway, Cambridge, London, Oxford

The UK’s medical and scientific base is regarded as one of the world’s best.

Feature
abpi_and_nihr_conference_nov13

Funding boost for UK drugs manufacturing

March 30, 2015
Manufacturing and Production, Sales and Marketing ABPI, AstraZeneca, BIA, Bristol-Myers Squibb, Britest, Cambridge, Cambridge Crystallographic Data Centre, GlaxoSmithKline, Perceptive Engineering, Pfizer, Process Systems Enterprise, UCB, University of Leeds, amsci, mmip, stfc

The UK government is funding new manufacturing partnerships that will improve design processes and supply chain initiatives to lift the …

News
Alzheimer’s Research UK image

£30m drug discovery centres launched to overcome pharma ‘funding fatigue’

February 18, 2015
Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma

Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …

News
Gilead image

Gilead expands UK presence with new London HQ

February 10, 2015
Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …

News
Manufacturing image

MHRA shuts down unlicensed cancer drug facility

February 9, 2015
Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor

The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …

News
Bennet Building bioscience laboratory image

Bioscience lab opens up in Cambridge

January 20, 2015
Research and Development AstraZeneca, BIA, Babraham Research Campus, Cambridge, Menelas Pangalos

The UK Bennet Building bioscience laboratory doors have been opened during a ceremony at the Babraham Research Campus in Cambridge …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024